Table 3 OAR dose evaluation

Right breast

mean dose [Gy]

3.7 (46.8%)

1.4

7.9

3.0

0.001*

D2% [Gy]

12.9 (63.5%)

4.8

20.3

7.4

0.029*

V10 [%]

7.4 (27.6%)

7.4

26.8

21.4

0.011*

V5 [%]

25.9 (43.6%)

13.5

59.4

17.1

< 0.001*

Right lung

mean dose [Gy]

3.6 (63.2%)

1.1

5.7

1.3

< 0.001*

D2% [Gy]

10.4 (67.1%)

2.2

15.5

4.9

0.004*

V10 [%]

2.9 (13.7%)

2.3

21.1

16.5

0.003*

V5 [%]

23.9 (71.6%)

12.2

33.4

22.4

0.431

Left lung

mean dose [Gy]

15.5 (91.2%)

1.4

17.0

1.1

0.052

D2% [Gy]

50.2 (101.0%)

1.1

49.7

1.9

0.354

V20 [%]

27.3 (89.5%)

2.4

30.5

2.2

0.013*

V10 [%]

45.7 (87.5%)

5.1

52.2

5.5

0.030*

V5 [%]

74.6 (87.4%)

11.5

85.4

5.0

0.016*

Heart

mean dose [Gy]

11.7 (78.5%)

3.0

14.9

4.5

0.062

D2% [Gy]

40.4 (99.5%)

8.3

40.6

9.1

1.000

V30 [%]

7.2 (69.2%)

4.0

10.4

9.7

0.708

V10 [%]

41.7 (74.9%)

16.3

55.7

17.8

0.062

V5 [%]

75.7 (81.7%)

15.4

92.6

10.1

0.030*